Accelerate Diagnostics, Inc
AXDXDelisted Jul 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000727207
Accelerate Diagnostics, Inc was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Apr 7, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $3.10M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Accelerate Diagnostics, Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 38 | 43 | +5 |
| Shares | 2.56M | 2.50M | −60.4K (−2.4%) |
| Value | $14.7M | $9.78M | −$4.92M (−33.4%) |
New holders (6)
Institutions that held Accelerate Diagnostics, Inc at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 15,446 | $60.5K | 0.00% |
| Millennium Management LLC | 13,947 | $54.7K | 0.00% |
| Cape Investment Advisory, Inc. | 300 | $1.18K | 0.00% |
| Rothschild Investment LLC | 160 | $627 | 0.00% |
| Northwest Bank & Trust Co | 140 | $548 | 0.00% |
| Baystate Wealth Management LLC | 50 | $196 | 0.00% |
Sold out (1)
Institutions that held Accelerate Diagnostics, Inc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Alyeska Investment Group, L.P. | 123,898 | $712.4K |